The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats

Phytomedicine

Volumn 23, Issue 12, 2016, Pages 1475-1483

  Lin, Zi ^a,b   Wu, Zheng Feng ^a,b   Jiang, Cui Hua ^a,b   Zhang, Qing Wen ^c   Ouyang, Sheng ^d,e   Che, Chun Tao ^e   Zhang, Jian ^b   Yin, Zhi Qi ^a,e  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Province Academy of Traditional Chinese Medicine   (China)

^c University of Macau   (Macao)

^d JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cyclocarya paliurus; Hepatic steatosis; Lipogenesis; Non alcoholic fatty liver disease; Proton magnetic resonance spectrum

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; APOLIPOPROTEIN B100; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CHOLESTEROL; CYCLOCARYA PALIURUS EXTRACT; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; FATTY ACID SYNTHASE; LIPID PEROXIDE; LIVER PROTECTIVE AGENT; MALONALDEHYDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLANT EXTRACT; SIMVASTATIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; LIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYCLOCARYA PALIURUS; DOWN REGULATION; DRUG EFFICACY; FAT CONTENT; FAT INTAKE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; HISTOPATHOLOGY; JUGLANDACEAE; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; LIVER HISTOLOGY; LIVER WEIGHT; MALE; MEDICINAL PLANT; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; BLOOD; CHINA; DRUG EFFECTS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ACETYL-COA CARBOXYLASE; ANIMALS; CHINA; CHOLESTEROL; DIET, HIGH-FAT; FATTY ACID SYNTHASES; FATTY ACIDS, NONESTERIFIED; JUGLANDACEAE; LIPIDS; LIPOGENESIS; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS, SPRAGUE-DAWLEY; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84985990170     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2016.08.003     Document Type: Article

References (49)

1. Adams, L.A., Angulo, P., Treatment of non-alcoholic fatty liver disease. Postgrad. Med. J. 82 (2006), 315–322.
2. 1H-MR spectroscopy imaging. Chin. J. Radiol. 41 (2007), 43–46.
3. Choi, S.S., Diehl, A.M., Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 19 (2008), 295–300.
4. Cui, W.X., Yang, J., Chen, X.Q., Mao, Q., Wei, X.L., Wen, X.D., Wang, Q., Triterpenoid-rich fraction from Ilex hainanensis Merr. Attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. Am. J. Chin. Med. 41 (2013), 487–502.
5. Day, C.P., James, O.F., Steatohepatitis: a tale of two ‘‘hits’’?. Gastroenterology 114 (1998), 842–845.
6. Dowman, J.K., Armstrong, M.J., Tomlinson, J.W., Newsome, P.N., Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes Obes. Metab. 13 (2011), 692–702.
7. Endo, M., Masaki, T., Seike, M., Yoshimatsu, H., TNF-α induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp. Biol. Med. 232 (2007), 614–621.
8. Feldstein, A.E., Werneburg, N.W., Canbay, A., Guicciardi, M.E., Bronk, S.F., Rydzewski, R., Burgart, L.J., Gores, G.J., Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 (2004), 185–194.
9. Gangadhar, K., Chintapalli, K.N., Cortez, G., Nair, S.V., MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods. Egypt. J. Radiol. Nucl. Med. 45 (2014), 619–626.
10. Hardie, D.G., Scott, J.W., Pan, D.A., Hudson, E.R., Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546 (2003), 113–120.
11. Higuchi, N., Kato, M., Shundo, Y., Tajiri, H., Tanaka, M., Yamashita, N., Kohjima, M., Kotoh, K., Nakamuta, M., Takayanagi, R., Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol. Res. 38 (2008), 1122–1129.
12. Hockings, P., Changani, K., Saeed, N., Reid, D., Birmingham, J., O'Brien, P., Osborne, J., Toseland, C., Buckingham, R., Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obes. Metab. 5 (2003), 234–243.
13. Hong, X.Z., Tang, H.Q., Wu, L.M., Li, L.D., Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J. Pharm. Pharmacol. 58 (2006), 1391–1398.
14. Jiang, C.H., Wang, Q.Q, Wei, Y.J., Yao, N., Wu, Z.F., Ma, Y.L., Lin, Z., Zhao, M., Che, C.T., Yao, X.M., Zhang, J., Yin, Z.Q., Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. J. Ethnopharmacol. 176 (2015), 17–26.
15. Jin, Y.J., Kim, K.M., Hwang, S., Lee, S.G., Ha, T.Y., Song, G.W., Jung, D.H., Kim, K.H., Yu, E., Shim, J.H., Lim, Y.S., Lee, H.C., Chung, Y.H., Lee, Y., Suh, D.J., Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J. Gastroenterol. Hepatol. 27 (2012), 1341–1347.
16. Kohjima, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., Enjoji, M., SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int. J. Mol. Med. 21 (2008), 507–511.
17. Kuzu, N., Bahcecioglu, I.H., Dagli, A.F., Ozercan, I.H., Ustundag, B., Sahin, K., Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. J. Gastroenterol. Hepatol. 23 (2008), e465–e470.
18. Li, S.T., Meng, F.Y., Liao, X.L., Wang, Y.M., Sun, Z.X., Guo, F.C., Li, X.X., Meng, M., Li, Y., Sun, C.H., Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One, 9, 2014, e86724.
19. Lieber, C.S., Leo, M.A., Mak, K.M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A., DeCarli, L.M., Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 79 (2004), 502–509.
20. Liu, L., Yang, M., Lin, X.M., Li, Y., Liu, C.J., Yang, Y.F., Yamahara, J., Wang, J.W., Li, Y.H., Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J. Ethnopharmacol. 150 (2013), 1045–1052.
21. 1H magnetic resonance spectroscopy. World Chin. J. Digestol. 16 (2008), 1612–1616.
22. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
23. Ma, Y.L., Jiang, C.H., Yao, N., Li, Y., Wang, Q.Q., Fang, S.Z., Shang, X.L., Zhao, M., Che, C.T., Ni, Y.C., Antihyperlipidemic effect of Cyclocarya paliurus (Batal.) Iljinskaja extract and inhibition of apolipoprotein B48 overproduction in hyperlipidemic mice. J. Ethnopharmacol. 166 (2015), 286–296.
24. Morgan, K., Uyuni, A., Nandgiri, G., Mao, L., Castaneda, L., Kathirvel, E., French, S.W., Morgan, T.R., Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 20 (2008), 843–854.
25. Nam, M.K., Choi, H.R., Cho, J.S., Cho, S.M., Ha, K.C., Kim, T.H., Ryu, H.Y., Lee, Y.I., Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice. Mol. Med. Rep. 10 (2014), 1821–1827.
26. Nguyen, P., Leray, V., Diez, M., Serisier, S., Le Bloc'h, J., Siliart, B., Dumon, H., Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. (Berl.) 92 (2008), 272–283.
27. Obika, M., Noguchi, H., Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp. Diabetes Res., 2012, 145754 2012.
28. Osborne, T.F., Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275 (2000), 32379–32382.
29. Ota, T., Gayet, C., Ginsberg, H.N., Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 118 (2008), 316–332.
30. Pang, X.Y., Yao, M.H., Lu, Y.Q., Gong, Q.Y., Effect of soy isoflavones on malondialdehyde and superoxide dismutase of blood and liver in hypercholesterolemia rats. Chin. J. New Drugs. Clin. Rem. 21 (2002), 257–261.
31. Petts, G., Lloyd, K., Goldin, R., Fatty liver disease. Diagn. Histopathol. 20 (2014), 102–108.
32. Phielix, E., Brehm, A., Bernroider, E., Krssak, M., Anderwald, C.H., Krebs, M., Schmid, A., Nowotny, P., Roden, M., Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes. Diabetes, Obesity Metab. 15 (2013), 915–922.
33. Postic, C., The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 34 (2009), 643–648.
34. Postic, C., Girard, J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118 (2008), 829–838.
35. Reeves, P.G., Nielsen, F.H., Fahey., G. Jr., AIN-93 purified diets for laboratory rodents: final report of the American institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993), 1939–1951.
36. Ryden, M., Arvidsson, E., Blomqvist, L., Perbeck, L., Dicker, A., Arner, P., Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem. Biophys. Res. Commun. 318 (2004), 168–175.
37. Schwenzer, N.F., Springer, F., Schraml, C., Stefan, N., Machann, J., Schick, F., Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 51 (2009), 433–445.
38. Song, Y., Lee, S.J., Jang, S.H., Ha, J.H., Song, Y.M., Ko, Y.G., Kim, H.D., Min, W., Kang, S.N., Cho, J.H., Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats. Nutrients 6 (2014), 2179–2195.
39. Sozio, M.S., Liangpunsakul, S., Crabb, D., The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin. Liver Dis. 30 (2010), 378–390.
40. Sumitra, M., Manikandan, P., Kumar, D.A., Arutselvan, N., Balakrishna, K., Manohar, B.M., Puvanakrishnan, R., Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol. Cell. Biochem. 224 (2001), 135–142.
41. Tilg, H., Moschen, A.R., Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52 (2010), 1836–1846.
42. Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., Tanikawa, K., Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J. Hepatol. 27 (1997), 103–107.
43. Viollet, B., Andreelli, F., Jorgensen, S.B., Perrin, C., Flamez, D., Mu, J., Wojtaszewski, J.F.P., Schuit, F.C., Birnbaum, M., Richter, E., Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31 (2003), 216–219.
44. Wang, N., Dong, H., Wei, S.C., Lu, F.E., Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease. J. Huazhong Univ. Sci. Technol. (Med. Sci.) 28 (2008), 295–298.
45. Wang, Q.Q., Jiang, C.H., Fang, S.Z., Wang, J.H., Ji, Y., Shang, X.L., Ni, Y.C., Yin, Z.Q., Zhang, J., Antihyperglycemic, antihyperlipidemic and antioxidant effects of ethanol and aqueous extracts of Cyclocarya paliurus leaves in type 2 diabetic rats. J. Ethnopharmacol. 150 (2013), 1119–1127.
46. Wong, V.W., Nonalcoholic fatty liver disease in Asia: a story of growth. J. Gastroenterol. Hepatol. 28 (2013), 18–23.
47. Yao, X.M., Lin, Z., Jiang, C.H., Gao, M., Wang, Q.Q., Yao, N., Ma, Y.L., Li, Y., Fang, S.Z., Shang, X.L., Ni, Y.C., Zhang, J., Yin, Z.Q., Cyclocarya paliurus prevents high fat diet induced hyperlipidemia and obesity in Sprague-Dawley rats. Can. J. Physiol. Pharmacol. 93 (2015), 677–686.
48. Yunoki, K., Sasaki, G., Tokuji, Y., Kinoshita, M., Naito, A., Aida, K., Ohnishi, M., Effect of dietary wine pomace extract and oleanolic acid on plasma lipids in rats fed high-fat diet and its DNA microarray analysis. J. Agric. Food Chem. 56 (2008), 12052–12058.
49. Zhu, K.N., Jiang, C.H., Tian, Y.S., Xiao, N., Wu, Z.F., Ma, Y.L., Lin, Z., Fang, S.Z., Shang, X.L., Liu, K., Zhang, J., Liu, B.L., Yin, Z.Q., Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation. Phytomedicine 22 (2015), 837–846.